Home » Stocks » BioNano Genomics

BioNano Genomics, Inc. (BNGO)

Stock Price: $0.798 USD -0.042 (-4.99%)
Updated Aug 11, 2020 4:00 PM EDT - Market closed
Pre-market: $0.800 +0.002 (0.24%) Aug 12, 7:02 AM

Stock Price Chart

Key Info

Market Cap 66.97M
Revenue (ttm) 9.41M
Net Income (ttm) -32.47M
Shares Out 136.99M
EPS (ttm) -1.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $0.798
Previous Close $0.840
Change ($) -0.042
Change (%) -4.99%
Day's Open 0.819
Day's Range 0.783 - 0.825
Day's Volume 12,847,269
52-Week Range 0.250 - 4.700

More Stats

Market Cap 66.97M
Enterprise Value 75.80M
Earnings Date (est) Aug 13, 2020
Ex-Dividend Date n/a
Shares Outstanding 136.99M
Float 82.49M
EPS (basic) -1.53
EPS (diluted) -1.52
FCF / Share -0.87
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.95M
Short Ratio 0.18
Short % of Float 5.55%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 7.12
PB Ratio 5.48
Revenue 9.41M
Operating Income -29.45M
Net Income -32.47M
Free Cash Flow -31.07M
Net Cash -8.83M
Net Cash / Share -0.11
Gross Margin 35.71%
Operating Margin -312.90%
Profit Margin -345.00%
FCF Margin -330.11%
ROA -75.67%
ROE -3,919.05%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(84.19% upside)
Current: $0.798
Target: 1.47
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-15.59%26.26%39.93%-
Gross Profit3.363.293.473.21
Operating Income-25.87-20.42-23.22-21.17
Net Income-29.82-18.50-23.37-18.85
Shares Outstanding14.987.082.7060.32
Earnings Per Share-1.99-2.61-8.65-312.46
Operating Cash Flow-29.53-19.94-20.82-23.50
Capital Expenditures-0.06-0.33-1.02-1.35
Free Cash Flow-29.59-20.28-21.84-24.85
Cash & Equivalents17.3116.521.025.25
Total Debt20.099.036.736.63
Net Cash / Debt-2.777.49-5.71-1.38
Book Value3.6110.14-50.23-27.26
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name BioNano Genomics, Inc.
Country United States
Employees 97
CEO Robert Erik Holmlin

Stock Information

Ticker Symbol BNGO
Stock Exchange NASDAQ
Unique Identifier NASDAQ: BNGO
IPO Date August 21, 2018


Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system includes an instrument, chip consumables, reagents, and a suite of data analysis tools. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its products for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in the United States and Canada, Europe, the Middle East, India, Africa, China, Japan, South Korea, Singapore, and Australia. The company was formerly known as BioNano Genomics, Inc. and changed its name to Bionano Genomics, Inc. in July 2018. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.